Congenital Adrenal Hyperplasia

Review
In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
.

Excerpt

Disorders of steroidogenesis resulting in deficiencies of cortisol and/or aldosterone are collectively referred to as Congenital Adrenal Hyperplasia (CAH). These autosomal recessive enzymatic defects are typified by pathogenic variants in CYP21A2 encoding 21-hydroxylase. Deficiency in this important enzyme leads to deficiency of cortisol synthesis and accumulation of precursors, such as 17-hydroxyprogesterone, which are then shunted into the androgen synthetic pathway. Consequently, affected female fetuses undergo virilization of the external genitalia in early gestation. In classic salt wasting CAH patients, the parallel pathway to aldosterone is also impaired. Newborn screening has been instrumental in earlier diagnosis, permitting prompt glucocorticoid and mineralocorticoid treatment. Inadequate or excessive steroid replacement may disrupt normal growth and pubertal progress in children and impair reproductive function and cardiometabolic health in adults. Owing to combined adrenal hormone deficiencies, CAH patients are at increased the risk for adrenal crises during stressful periods. Here we discuss the characteristics of several enzyme defects and describe current and new treatment strategies. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.

Publication types

  • Review